Home/Filings/3/0001104659-25-078710
3//SEC Filing

Shaf QIC LLC 3

Accession 0001104659-25-078710

CIK 0001374339other

Filed

Aug 13, 8:00 PM ET

Accepted

Aug 14, 4:40 PM ET

Size

23.2 KB

Accession

0001104659-25-078710

Insider Transaction Report

Form 3
Period: 2025-07-29
Holdings
  • Warrants (right to buy)

    Exercise: $1.25Exp: 2030-07-29Common Shares (4,186,049 underlying)
  • Common Shares

    5,184,760
  • Warrants (right to buy)

    Exercise: $7.50Exp: 2028-04-11Common Shares (100,000 underlying)
  • Warrants (right to buy)

    Exercise: $1.75Exp: 2029-02-23Common Shares (1,063,830 underlying)
Shaf QIC LLC
10% Owner
Holdings
  • Warrants (right to buy)

    Exercise: $1.75Exp: 2029-02-23Common Shares (1,063,830 underlying)
  • Warrants (right to buy)

    Exercise: $7.50Exp: 2028-04-11Common Shares (100,000 underlying)
  • Common Shares

    5,184,760
  • Warrants (right to buy)

    Exercise: $1.25Exp: 2030-07-29Common Shares (4,186,049 underlying)
Footnotes (2)
  • [F1]Represents Common Shares issuable upon exercise of a warrant that is currently exercisable.
  • [F2]Represents Common Shares issuable upon exercise of warrants that are currently exercisable. The reported warrants contain provisions preventing their exercise to the extent that such exercise would result in the holder (together with its affiliates) obtaining greater than 9.99% of the Issuer's Common Shares.

Issuer

ProMIS Neurosciences Inc.

CIK 0001374339

Entity typeother
IncorporatedNH

Related Parties

1
  • filerCIK 0002038058

Filing Metadata

Form type
3
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:40 PM ET
Size
23.2 KB